APA (7th ed.) Citation

Blay, J., & Hohenberger, P. (2014). Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas. European journal of cancer, 50(6), . https://doi.org/10.1016/j.ejca.2014.01.012

Chicago Style (17th ed.) Citation

Blay, Jean-Yves, and Peter Hohenberger. "Randomised Phase III Trial of Trabectedin Versus Doxorubicin-based Chemotherapy as First-line Therapy in Translocation-related Sarcomas." European Journal of Cancer 50, no. 6 (2014). https://doi.org/10.1016/j.ejca.2014.01.012.

MLA (9th ed.) Citation

Blay, Jean-Yves, and Peter Hohenberger. "Randomised Phase III Trial of Trabectedin Versus Doxorubicin-based Chemotherapy as First-line Therapy in Translocation-related Sarcomas." European Journal of Cancer, vol. 50, no. 6, 2014, https://doi.org/10.1016/j.ejca.2014.01.012.